Publicaciones en las que colabora con Juan Marco Figueira Gonçalves (28)

2024

  1. Comment on “Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease”

    Archivos de Bronconeumologia

  2. Oxygen therapy could improve survival in patients with early desaturation in the 6-minute walk test: A post hoc analysis

    Respirology

2023

  1. A Novel Figure and Algorithm for the GOLD-ABE Classification: Additional Comments

    Archivos de Bronconeumologia

  2. Classification of the Severity of COPD Exacerbations in Hospitalized Patients According to Rome vs GesEPOC Criteria

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 57-58

  3. Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD

    Lung, Vol. 201, Núm. 2, pp. 217-224

  4. Impact of Oral Antidiabetics Agents in the Prevention of COPD Exacerbations

    Archivos de Bronconeumologia

  5. Nocturnal Dyspnea During Severe Exacerbations Is Associated With Mortality Risk in COPD

    Respiratory care, Vol. 68, Núm. 3, pp. 413-416

  6. Relationship Between the Summation of GesEPOC High-Risk Factors and the Presence of Cardiovascular Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 403-405

  7. The Relevance of Comorbidities in the Persistence of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease

    Open Respiratory Archives, Vol. 5, Núm. 3

  8. Ultrasound assessment of diaphragmatic dynamics in patients with chronic obstructive pulmonary disease after treatment with indacaterol/glycopyrronium

    Revista Clinica Espanola, Vol. 223, Núm. 4, pp. 216-222

2022

  1. A new, three-dimensional approach to the GOLD COPD assessment tool

    Respiratory Medicine and Research, Vol. 81

  2. Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA study

    Clinical Respiratory Journal, Vol. 16, Núm. 7, pp. 504-512

  3. Impact of the Pandemia on Physical Activity in Patients with Chronic Obstructive Pulmonary Disease

    Open Respiratory Archives

  4. Medium- and Long-Term Consequences of SARS-CoV-2 Infection on COPD Patients

    Archivos de Bronconeumologia

  5. Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. 451-453

  6. Should we overcome «flat earth» in the treatment of chronic obstructive pulmonary disease?

    Open Respiratory Archives

  7. Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk

    Lung, Vol. 200, Núm. 5, pp. 601-607

2021

  1. Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC Guideline vs. GOLD

    Revista Clinica Espanola, Vol. 221, Núm. 9, pp. 536-539

  2. Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?

    Archivos de Bronconeumologia

  3. Post-COVID syndrome in the patient with chronic obstructive pulmonary disease: A Trojan horse?

    Semergen